News for Providers
Top stories summarized by our editors
1/21/2019

Pets can be seriously injured if they slip and fall on ice, de-icing salts and chemicals can irritate pets' paws and cause gastrointestinal problems if swallowed, and ice can also cut and abrade paws, according to the AVMA. Pets should be closely supervised and protected in icy weather, and their paws, legs and belly should be thoroughly wiped down after exposure to ice, snow and de-icers.

Full Story:
WDIV-TV (Detroit)
1/21/2019

JPMorgan Chase executive Anne Motsenbocker has had to learn to appreciate feedback, both received and given. "Personally, I now seek out feedback, and I am committed to sharing feedback with others to help them be their best," she says.

1/21/2019

Mayo Clinic researchers conducted a randomized, double-blind Phase II study involving patients with type 2 diabetes and found that those who received the oral hepatoselective glucokinase activator TTP399 had a clinically significant and sustained A1C reduction from baseline, compared with those on placebo. The findings in Science Translational Medicine also revealed that those who received TTP399 at 800 mg/day had reduced fasting plasma glucagon, increased HDL cholesterol, and reduced weight among patients weighing at least 100 kg.

1/21/2019

An FDA advisory committee voted 8-8 Thursday over whether the agency should allow Sanofi and Lexicon Pharmaceuticals' Zynquista, or sotagliflozin, to reach the market. Results of three clinical trials involving nearly 3,000 type 1 diabetes patients showed that although the drug helped reduce blood glucose levels, blood pressure and weight, 3.2% of 1,748 patients developed diabetic ketoacidosis, compared with 0.4% of 1,229 patients on placebo.

1/21/2019

A Mercom Capital Group report showed digital health investing spiked in 2018, with 698 deals for venture capital and private equity funding totaling almost $9.5 billion. Companies that focused on data analytics, wearables, mobile health apps, practice management solutions and mobile wireless received the most venture capital.

Full Story:
Healthcare Dive
1/21/2019

Hospitals in Charleston, S.C., are making strategic moves to counter shifts in inpatient numbers, in some cases consolidating services or aligning them more closely with where people live and work. East Cooper Medical Center CEO Patrick Downes said even though the facility is seeing inpatient growth it is looking for other options as the demand for services shifts.

1/21/2019

Health care must change its narrative about patient safety so that reaching a goal of zero patient deaths from hospital infections is seen as feasible, Dr. Peter Pronovost told a Patient Safety Movement Foundation summit. MedStar Health Vice President David Mayer, who helped create the Communication and Optimal Resolution Toolkit, was named new CEO of the Patient Safety Movement Foundation.

1/21/2019

A report from UserTesting, a company offering an on-demand human insight platform, found health care chatbots aren't quite meeting users' expectations, particularly when it comes to trust, handling complex conditions and usability. UserTesting ran a study of five health care chatbot apps: Ada, HealthTap, Mediktor, Your.MD and Symptomate.

Full Story:
MedCity News
1/21/2019

Scientists at the Van Andel Research Institute found that a breakthrough approach combining the new blood test measuring sTRA sugar with the standard test measuring CA-19-9 sugar was able to identify nearly 70% of pancreatic cancers with a false-positive rate below 5%, compared with the 40% of pancreatic cancers detected by the CA-19-9 test alone. The approach, described in the journal Clinical Cancer Research, "could be a simple, cost-effective way to detect disease early enough to improve patient outcomes," said researcher Brian Haab.

1/21/2019

The first patient with metastatic cancer was enrolled by ImaginAb in a midstage trial of its IAB22M2C immuno-PET imaging agent, which is intended for the noninvasive measurement of cancer patients' CD8+ T-cell tumor infiltrates. The study will determine the association between observed imaging signals, standard-of-care imaging scans and CD8 immunohistochemistry analysis in biopsied tissues, as well as measure immuno-oncology therapy-related changes in CD8+ T-cell distribution.

Full Story:
PR Newswire